Sign in

GILEAD SCIENCES, INC.

Income Statement - GILEAD SCIENCES, INC. (GILD)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Total revenue 29.44 28.75 27.12 27.28 27.31 24.69 22.45 22.13 26.11 30.39 32.64 24.89 11.20 9.70 8.39 7.95 7.01 5.34 4.23 3.03
Cost of revenue 6.23 6.25 5.80 5.66 6.60 4.57 4.68 4.85 4.37 4.26 4.01 3.79 2.86 2.47 2.12 1.87 1.60 1.13 0.77 0.43
Gross profit 23.21 22.50 27.12 21.62 20.70 20.12 17.77 17.27 21.74 26.13 28.63 21.10 8.34 7.23 6.26 6.08 5.42 4.21 3.46 2.59
Total operating expenses + 11.51 20.84 11.81 14.29 10.79 16.05 8.44 7.98 7.61 8.50 6.44 5.84 3.82 3.22 2.47 2.12 1.89 1.52 1.30 0.96
Operating income 11.70 1.66 7.61 7.33 9.92 4.07 4.29 8.20 14.12 17.63 22.19 15.27 4.52 4.01 3.79 3.96 3.53 2.68 2.16 -0.76
Non-operating income (net) -1.91 -0.97 -0.75 -1.52 -1.64 -2.40 0.87 -0.40 -0.60 -0.54 -0.53 -0.41 -0.32 -0.40 -0.14 -0.05 -0.03 -0.01 0.11 0.12
Income before tax 9.80 0.69 6.86 5.81 8.28 1.67 5.16 7.80 13.53 17.10 21.66 14.86 4.21 3.61 3.65 3.91 3.50 2.67 2.27 -0.64
Income tax expense 1.29 0.21 -1.25 1.25 2.08 1.58 -0.20 2.34 8.89 3.61 3.55 2.80 1.15 1.04 0.86 1.02 0.88 0.70 0.66 0.55
Net income 8.51 0.48 5.67 4.59 6.23 0.12 5.39 5.46 4.63 13.50 18.11 12.10 3.08 2.59 2.80 2.90 2.64 1.98 1.62 -1.19
Show Quarterly Income Statement

Income Statement - GILEAD SCIENCES, INC. (GILD)

$(Billion, Million)
Jun-26 Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Total revenue 7.80 6.96 7.92 7.77 7.08 6.67 7.57 7.55 6.95 6.69 7.11 7.05 6.60 6.35 7.39 7.04 6.26 6.59 7.24 7.42 6.22 6.42 7.42 6.58 5.14 5.55 5.88 5.60 5.69 5.28 5.80 5.60 5.65 5.09 5.95 6.51 7.14 6.51 7.32 7.50 7.78 7.79 8.51 8.30 8.24 7.59 7.31 6.04 6.54 5.00 3.12 2.78 2.77 2.53 2.59 2.43 2.41 2.28 2.20 2.12 2.14 1.93 2.00 1.94 1.93 2.09 2.03 1.80 1.65 1.53 1.43 1.37 1.28 1.26 1.09 1.06 1.05 1.03 0.90 0.75 0.69 0.69
Cost of revenue 1.58 1.45 1.62 1.57 1.50 1.54 1.58 1.57 1.54 1.55 2.09 1.57 1.44 1.40 1.40 1.40 1.44 1.42 2.63 1.22 1.39 1.36 1.40 1.14 1.06 0.97 1.68 1.04 1.00 0.96 1.57 1.09 1.20 1.00 1.26 1.03 1.13 0.96 1.08 1.13 0.86 1.19 1.06 1.06 1.00 0.88 1.06 0.99 0.93 0.81 0.86 0.68 0.68 0.63 0.68 0.60 0.62 0.58 0.58 0.53 0.53 0.47 0.50 0.48 0.46 0.44 0.47 0.41 0.38 0.33 0.32 0.30 0.27 0.24 0.22 0.20 0.18 0.17 0.16 0.11 0.08 0.09
Gross profit 6.22 5.52 6.30 6.20 5.58 5.13 5.99 5.97 5.41 5.13 5.02 5.49 5.16 4.95 5.99 5.65 4.82 5.17 4.62 6.20 4.83 5.06 6.02 5.44 4.08 4.58 4.20 4.57 4.69 4.32 4.23 4.51 4.45 4.09 4.69 5.48 6.02 5.55 6.25 6.37 6.91 6.60 7.44 7.23 7.25 6.71 6.25 5.06 5.61 4.19 2.26 2.10 2.08 1.90 1.91 1.83 1.79 1.70 1.62 1.59 1.60 1.45 1.50 1.46 1.47 1.65 1.56 1.39 1.26 1.20 1.11 1.07 1.01 1.02 0.88 0.86 0.86 0.86 0.74 0.64 0.61 0.60
Total operating expenses + 16.62 2.93 3.31 2.87 3.11 2.89 3.54 5.08 2.77 9.46 3.41 2.86 3.49 3.25 3.73 2.81 2.79 4.97 3.68 2.36 2.58 2.17 3.37 3.44 7.06 2.18 3.10 6.04 2.26 2.09 3.08 1.89 2.17 1.93 2.40 1.67 1.76 1.78 2.20 1.97 2.37 1.95 1.82 1.65 1.63 1.34 1.92 1.58 1.20 1.14 1.07 0.95 0.93 0.87 0.81 0.79 0.73 0.90 0.75 0.59 0.59 0.55 0.67 0.48 0.48 0.48 0.49 0.50 0.50 0.39 0.40 0.38 0.41 0.35 0.36 0.31 0.32 0.30 2.30 0.58 0.24 0.23
Operating income -10.39 2.69 2.99 3.33 2.47 2.24 2.45 0.89 2.64 -4.32 1.61 2.62 1.67 1.71 2.27 2.84 2.03 0.20 0.94 3.84 2.25 2.89 2.65 2.00 -2.98 2.40 1.09 -1.47 2.43 2.24 1.14 2.62 2.28 2.15 2.29 3.81 4.25 3.77 4.05 4.40 4.54 4.65 5.62 5.59 5.62 5.37 4.33 3.48 4.41 3.04 1.20 1.15 1.15 1.03 1.11 1.04 1.06 0.80 0.87 1.00 1.02 0.90 0.83 0.98 0.99 1.16 1.07 0.89 0.76 0.81 0.71 0.69 0.61 0.67 0.51 0.55 0.54 0.56 -1.55 0.06 0.37 0.37
Non-operating income (net) 0.14 -0.11 -0.91 0.31 -0.05 -0.59 -0.29 0.07 -0.59 -0.16 0.04 -0.31 -0.08 -0.41 -0.24 -0.41 -0.53 -0.35 -0.18 -0.40 -0.43 -0.63 -0.84 -1.18 0.01 -0.40 0.81 -0.03 -0.02 0.11 -0.13 0.04 -0.19 -0.12 -0.17 -0.14 -0.14 -0.15 -0.13 -0.12 -0.14 -0.15 -0.18 -0.11 -0.11 -0.13 -0.10 -0.11 -0.11 -0.09 -0.08 -0.07 -0.08 -0.09 -0.08 -0.09 -0.09 -0.13 -0.05 -0.03 -0.03 -0.03 -0.03 -0.02 0.00 0.00 -0.01 0.00 -0.01 -0.01 0.02 0.00 0.00 0.01 0.03 0.03 0.03 0.02 0.03 0.03 0.03 0.03
Income before tax -10.25 2.58 2.08 3.64 2.43 1.65 2.17 0.96 2.05 -4.49 1.65 2.32 1.59 1.30 2.03 2.43 1.50 -0.15 0.76 3.44 1.82 2.26 1.81 0.83 -2.97 2.00 1.90 -1.50 2.41 2.35 1.02 2.66 2.09 2.03 2.13 3.67 4.12 3.62 3.92 4.28 4.40 4.50 5.44 5.47 5.51 5.24 4.23 3.37 4.31 2.95 1.11 1.08 1.08 0.94 1.02 0.95 0.97 0.67 0.82 0.97 0.98 0.87 0.80 0.96 0.99 1.16 1.06 0.89 0.76 0.80 0.73 0.70 0.60 0.67 0.54 0.58 0.57 0.58 -1.52 0.09 0.40 0.40
Income tax expense 0.24 0.56 -0.11 0.59 0.47 0.33 0.39 -0.30 0.44 -0.32 0.24 0.15 0.55 0.32 0.40 0.65 0.37 -0.16 0.38 0.85 0.30 0.54 0.27 0.47 0.37 0.47 -0.79 -0.33 0.54 0.38 1.01 0.57 0.27 0.49 5.96 0.96 1.05 0.92 0.82 0.95 0.90 0.94 0.75 0.88 1.01 0.91 0.77 0.65 0.66 0.73 0.33 0.29 0.31 0.22 0.26 0.28 0.26 0.23 0.16 0.24 0.24 0.23 0.17 0.26 0.28 0.31 0.26 0.22 0.19 0.21 0.16 0.19 0.17 0.19 0.14 0.18 0.16 0.17 0.14 0.14 0.13 0.13
Net income -10.50 2.02 2.18 3.05 1.96 1.32 1.78 1.25 1.61 -4.17 1.43 2.18 1.05 1.01 1.64 1.79 1.14 0.02 0.38 2.59 1.52 1.73 1.55 0.36 -3.34 1.55 2.70 -1.17 1.88 1.98 0.00 2.10 1.82 1.54 -3.87 2.72 3.07 2.70 3.11 3.33 3.50 3.57 4.68 4.60 4.49 4.33 3.49 2.73 3.66 2.23 0.79 0.79 0.77 0.72 0.76 0.68 0.71 0.44 0.67 0.74 0.75 0.65 0.63 0.70 0.71 0.85 0.80 0.67 0.57 0.59 0.57 0.50 0.43 0.49 0.40 0.40 0.41 0.41 -1.67 -0.05 0.27 0.26
about 2 months ago

Balance Sheet - GILEAD SCIENCES, INC. (GILD)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Total cash and short-term investments + 9.61 11.57 7.26 6.39 6.52 7.41 24.35 30.09 25.51 11.90 14.61 10.13 2.13 1.86 9.90 2.10 1.66 1.79 1.17 0.94
Accounts receivable, net 4.91 4.42 4.66 4.78 4.49 4.89 3.58 3.33 3.85 4.51 5.85 4.64 2.18 1.75 1.95 1.62 1.39 1.02 0.80 0.61
Inventories 1.77 1.71 1.79 1.51 1.62 1.68 0.92 0.81 0.80 1.59 1.96 1.39 1.70 1.74 1.39 1.20 1.05 0.93 0.60 0.56
Other current assets 2.04 1.48 2.37 1.77 2.14 2.01 1.44 1.61 1.66 1.06 0.51 0.47 0.99 0.80 0.68 0.78 0.71 0.54 0.46 0.32
Total current assets 18.34 19.17 16.09 14.44 14.77 16.00 30.30 35.84 31.82 38.48 34.02 17.75 7.00 6.16 13.92 5.71 4.81 4.28 3.03 2.43
Total non-current assets + 40.68 39.82 46.04 48.73 53.18 52.41 31.33 27.84 38.46 18.50 17.82 16.92 15.58 15.08 3.38 5.88 4.89 2.66 2.81 1.66
Total assets 59.02 59.00 62.13 63.17 67.95 68.41 61.63 63.68 70.28 56.98 51.84 34.66 22.58 21.24 17.30 11.59 9.70 6.94 5.83 4.09
Total current liabilities + 11.81 12.00 11.28 11.24 11.61 11.40 9.76 10.61 11.64 9.22 9.89 5.62 6.41 4.24 2.51 2.46 1.87 1.22 0.74 0.76
Total non-current liabilities + 24.59 27.75 28.10 30.72 35.28 38.79 29.22 31.54 38.15 28.40 22.84 13.23 4.43 7.46 7.92 3.01 1.32 1.25 1.50 1.45
Total liabilities 36.41 39.75 39.38 41.96 46.89 50.19 38.98 42.14 49.78 37.61 32.73 18.85 10.83 11.70 10.44 5.47 3.19 2.47 2.23 2.22
Total stockholders' equity + 22.70 19.33 22.83 21.24 21.07 18.20 22.53 21.39 20.44 19.36 19.11 15.82 11.37 9.30 6.74 5.86 6.37 4.27 3.46 1.82
Common shares outstanding 1,255 1,255 1,258 1,262 1,262 1,263 1,277 1,308 1,319 1,358 1,521 1,647 1,695 1,583 1,580 1,747 1,868 1,918 1,929 1,836
Show Quarterly Balance Sheet

Balance Sheet - GILEAD SCIENCES, INC. (GILD)

$(Billion, Million)
Jun-26 Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Total cash and short-term investments + 3.18 7.64 9.61 7.35 5.21 8.71 11.57 6.70 4.20 6.06 8.35 6.86 6.67 5.87 6.39 5.66 5.66 5.33 6.52 5.74 6.53 5.67 7.41 23.98 18.91 20.79 24.35 22.86 27.18 27.90 30.09 28.47 25.92 24.00 25.51 28.39 21.10 14.12 11.90 12.27 8.75 8.32 14.61 15.71 8.61 11.29 10.13 6.32 8.80 6.47 2.13 2.09 2.29 1.94 1.86 1.70 1.71 1.45 9.90 2.26 2.27 3.01 2.10 2.31 2.00 1.65 1.66 1.36 1.24 2.06 1.79 1.92 1.35 0.91 1.17 0.77 0.88 0.93 0.94 2.85 1.49 2.54
Accounts receivable, net 5.06 4.74 4.91 5.10 4.78 4.39 4.42 4.59 4.66 4.67 4.66 4.79 4.23 4.16 4.78 4.35 4.12 3.79 4.49 4.57 4.15 3.93 4.89 3.91 3.19 3.91 3.58 3.32 3.40 3.28 3.33 3.47 3.54 3.78 3.85 4.12 4.48 4.03 4.51 5.08 5.75 6.16 5.85 6.11 5.33 4.84 4.64 2.85 3.44 3.24 2.10 1.97 1.90 1.95 1.75 1.77 1.70 2.16 1.95 1.87 1.94 1.80 1.62 1.67 1.48 1.49 1.39 1.34 1.24 1.07 1.02 1.05 1.02 0.98 0.80 0.80 0.73 0.69 0.61 0.59 0.49 0.43
Inventories 4.30 1.91 1.77 1.79 1.83 1.76 1.71 1.87 2.03 1.85 1.79 1.66 1.63 1.58 1.51 1.46 1.49 1.48 1.62 1.68 1.77 1.78 1.68 1.01 1.05 0.99 0.92 0.88 0.88 0.90 0.81 0.82 0.86 0.89 0.80 1.14 1.41 1.47 1.59 1.90 1.86 1.88 1.96 1.99 2.04 1.91 1.39 1.91 2.07 2.14 2.06 1.95 1.94 1.80 1.74 1.62 1.60 1.42 1.39 1.34 1.32 1.30 1.20 1.27 1.36 1.22 1.05 1.02 0.97 0.94 0.93 0.90 0.86 0.66 0.60 0.57 0.57 0.52 0.56 0.37 0.32 0.22
Other current assets 4.34 2.04 3.65 2.90 2.83 1.48 1.63 1.43 1.46 1.29 2.66 1.76 1.85 1.77 2.08 1.90 2.04 2.14 2.01 1.48 1.91 2.01 2.03 1.48 1.27 1.44 1.31 2.26 1.94 1.61 2.17 2.41 1.60 1.66 1.66 1.61 1.80 1.06 2.18 1.99 2.91 0.51 2.10 0.55 0.76 0.47 0.27 0.20 0.20 0.09 0.96 0.95 0.98 0.80 0.80 0.83 0.79 0.68 0.69 0.69 0.73 0.78 0.78 0.87 0.76 0.71 0.59 0.54 0.55 0.54 0.46 0.44 0.39 0.46 0.41 0.26 0.30 0.32 0.22 0.20 0.18
Total current assets 12.53 18.64 18.34 17.87 14.72 16.90 19.17 14.78 12.32 14.04 16.09 15.98 14.29 13.46 14.44 13.55 13.18 12.63 14.77 13.99 13.93 13.28 16.00 30.93 24.64 26.95 30.30 28.36 33.73 34.02 35.84 34.92 32.73 30.26 31.82 35.32 42.46 39.53 38.48 21.43 18.35 19.27 34.02 33.21 22.04 21.26 17.75 12.45 15.09 12.24 6.73 6.97 7.07 6.66 6.16 5.88 5.84 5.83 13.92 6.15 6.22 6.85 5.71 6.03 5.71 5.12 4.81 4.30 4.00 4.62 4.28 4.33 3.67 2.95 3.03 2.55 2.45 2.44 2.43 4.03 2.49 3.38
Total non-current assets + 36.83 37.64 40.68 40.66 41.01 39.53 39.82 39.74 41.26 42.25 46.04 46.39 48.05 48.42 48.73 49.00 49.69 50.45 53.18 53.11 54.06 54.21 52.41 29.95 31.29 32.79 31.33 30.79 29.48 28.81 27.84 29.39 32.63 35.12 38.46 29.35 17.80 18.18 18.50 35.18 31.63 28.50 17.82 17.43 17.13 17.06 16.92 16.39 16.12 15.84 15.77 15.50 15.55 15.55 15.08 15.08 14.66 14.12 3.38 6.49 6.48 6.14 5.88 5.42 4.79 5.57 4.89 4.64 4.39 2.90 2.66 2.65 2.85 2.93 2.81 2.77 2.38 2.17 1.66 1.27 2.69 0.66
Total assets 49.36 56.28 59.02 58.53 55.72 56.43 59.00 54.53 53.58 56.29 62.13 62.37 62.34 61.88 63.17 62.56 62.87 63.08 67.95 67.10 67.98 67.49 68.41 60.88 55.93 59.74 61.63 59.15 63.21 62.84 63.68 64.31 65.36 65.38 70.28 64.66 60.26 57.70 56.98 56.61 49.98 47.77 51.84 50.64 39.17 38.32 34.66 28.84 31.21 28.08 22.50 22.47 22.62 22.21 21.24 20.96 20.50 19.95 17.30 12.64 12.69 12.99 11.59 11.46 10.50 10.70 9.70 8.94 8.39 7.52 6.94 6.97 6.52 5.88 5.83 5.32 4.83 4.62 4.09 5.30 5.18 4.04
Total current liabilities + 11.02 9.48 11.81 12.30 11.19 12.34 12.00 11.72 10.78 13.02 11.28 11.95 13.96 10.53 11.24 10.42 9.22 8.56 11.61 10.25 10.21 9.71 11.40 9.51 10.56 8.88 9.76 9.57 8.96 9.40 10.61 10.12 10.91 10.67 11.64 9.60 8.49 8.28 9.22 11.07 10.44 10.91 9.89 9.36 8.93 7.43 5.62 6.05 6.23 5.91 6.33 4.90 4.94 4.29 4.24 4.80 4.99 4.19 2.51 2.22 2.31 2.77 2.46 2.59 3.11 1.89 1.87 1.89 1.78 1.26 1.22 1.26 2.45 0.94 0.74 0.69 0.75 0.71 0.76 0.58 0.51 0.42
Total non-current liabilities + 26.60 23.37 24.59 24.78 24.94 25.01 27.75 24.41 24.60 25.82 28.10 28.19 27.28 30.41 30.72 31.08 33.44 34.61 35.28 35.38 38.06 38.82 38.79 33.90 27.23 28.68 29.22 28.84 31.50 31.35 31.54 31.18 32.71 34.06 38.15 29.81 28.68 28.50 28.40 28.18 23.42 22.84 22.84 23.33 13.61 13.31 13.23 8.93 8.55 8.46 4.43 6.38 6.34 7.53 7.46 7.41 7.43 8.40 7.92 4.18 4.17 4.04 3.01 2.99 0.69 1.31 1.32 1.30 1.30 1.24 1.25 1.42 0.20 1.50 1.50 1.48 1.47 1.46 1.45 1.42 1.47 0.22
Total liabilities 37.62 32.85 36.41 37.08 36.13 37.36 39.75 36.14 35.38 38.84 39.38 40.13 41.24 40.94 41.96 41.50 42.66 43.17 46.89 45.63 48.27 48.53 50.19 43.41 37.79 37.56 38.98 38.41 40.46 40.75 42.14 41.30 43.62 44.73 49.78 39.41 37.17 36.78 37.61 39.25 33.87 33.75 32.73 32.69 22.53 20.73 18.85 14.98 14.78 14.38 10.75 11.28 11.28 11.82 11.70 12.21 12.42 12.59 10.44 6.41 6.48 6.81 5.47 5.58 3.80 3.19 3.19 3.18 3.07 2.50 2.47 2.68 2.65 2.44 2.23 2.17 2.23 2.17 2.22 2.00 1.98 0.64
Total stockholders' equity + 11.74 23.52 22.70 21.54 19.68 19.16 19.33 18.47 18.28 17.54 22.83 22.31 21.16 21.00 21.24 21.08 20.24 19.93 21.07 21.47 19.70 18.95 18.20 17.45 18.03 22.07 22.53 20.60 22.62 21.95 21.39 22.86 21.67 20.59 20.44 24.85 23.09 20.92 19.36 16.87 15.54 13.40 19.11 17.94 16.63 17.59 15.82 13.86 16.43 13.70 11.74 10.88 11.09 10.15 9.30 8.60 8.00 7.31 6.74 6.12 6.05 5.95 5.86 5.71 6.56 7.34 6.37 5.65 5.19 4.80 4.27 4.17 3.77 3.33 3.46 2.98 2.49 2.38 1.82 3.30 3.20 3.39
Common shares outstanding 1,243 1,254 1,253 1,254 1,255 1,259 1,259 1,254 1,251 1,247 1,256 1,257 1,258 1,261 1,264 1,261 1,260 1,262 1,262 1,262 1,260 1,262 1,259 1,261 1,255 1,270 1,273 1,267 1,277 1,283 1,299 1,307 1,308 1,320 1,307 1,319 1,317 1,320 1,327 1,339 1,355 1,412 1,472 1,503 1,540 1,569 1,597 1,637 1,664 1,680 1,694 1,692 1,695 1,665 1,637 1,585 1,561 1,555 1,534 1,563 1,602 1,624 1,666 1,694 1,798 1,857 1,807 1,865 1,869 1,885 1,842 1,921 1,931 1,933 1,854 1,918 1,936 1,925 1,830 1,830 1,905 1,927
about 2 months ago

Cash Flow - GILEAD SCIENCES, INC. (GILD)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Operating cash flow + 10.02 10.83 8.01 9.07 11.38 8.17 9.14 8.40 11.90 17.05 21.25 12.82 3.11 3.20 3.64 2.83 3.08 2.14 1.77 1.22
Cash flow from investing + -4.79 -3.45 -2.27 -2.47 -3.13 -14.62 -7.82 14.36 -16.07 -11.99 -12.48 -1.82 -0.25 -11.85 3.59 -1.94 -2.22 -0.18 -1.30 -1.74
Cash flow from financing + -7.75 -3.43 -5.13 -6.47 -8.88 0.77 -7.63 -12.32 3.39 -9.73 -5.88 -3.03 -2.54 0.56 1.76 -1.34 -1.05 -1.47 -0.27 0.65
Change in cash -2.52 3.95 0.62 0.14 -0.62 -5.68 -6.31 10.35 -0.64 -4.62 2.82 7.91 0.31 -8.08 8.98 -0.37 -0.19 0.49 0.20 0.13
Change in exchange rate -0.09 0.14 0.04 -0.07 -0.06 0.00 0.01 -0.02 0.08 0.00
Show Quarterly Cash Flow

Cash Flow - GILEAD SCIENCES, INC. (GILD)

$(Billion, Million)
Jun-26 Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Operating cash flow + 3.57 2.54 3.33 4.11 0.83 1.76 2.98 4.31 1.33 2.22 2.17 1.76 2.34 1.74 2.57 2.86 1.80 1.84 3.21 3.25 2.32 2.61 1.92 2.25 2.57 1.44 2.58 2.65 2.34 1.58 2.35 2.21 1.57 2.27 2.75 2.69 3.53 2.93 3.49 4.39 4.99 4.13 4.87 4.10 5.66 5.70 3.02 4.04 4.19 1.57 0.73 0.75 0.95 0.67 0.71 0.75 1.29 0.45 0.98 0.90 0.94 0.82 0.72 0.74 0.70 0.67 0.96 0.86 0.62 0.64 0.65 0.51 0.44 0.61 0.51 0.25 0.51 0.49 0.48 0.25 0.27 0.22
Cash flow from investing + -10.35 1.77 -1.84 -0.43 -2.12 -0.42 -0.23 -0.71 -0.31 -2.21 -0.73 -0.23 -0.48 -0.83 -0.38 -0.71 -0.31 -1.07 -0.28 -0.23 -0.58 -2.04 -8.98 -0.27 -5.02 -0.34 0.43 -1.84 -6.16 -0.24 2.74 2.03 5.24 4.35 -10.02 -2.11 -4.25 0.31 -2.68 -3.92 -3.28 -2.11 -2.44 -4.19 -3.55 -2.30 -0.40 -0.77 -0.49 -0.16 0.22 -0.01 -0.06 -0.41 0.05 -0.52 -0.63 -10.74 4.44 -0.08 -0.47 -0.30 -0.41 -1.39 0.93 -1.07 -0.40 -0.43 -1.06 -0.33 0.24 -0.32 0.02 -0.12 -0.13 -0.40 -0.18 -0.59 -0.24 -0.59 -0.22 -0.69
Cash flow from financing + 2.34 -4.24 -1.26 -1.49 -1.57 -3.43 2.26 -1.38 -2.95 -1.36 -1.10 -1.52 -1.10 -1.41 -1.55 -2.12 -1.00 -1.79 -1.94 -3.53 -0.93 -2.48 0.13 4.12 -0.87 -2.61 -0.90 -2.52 -1.86 -2.37 -1.67 -2.90 -1.15 -6.60 3.35 2.17 -0.88 -1.24 -2.30 2.80 -1.56 -8.61 -3.54 6.64 -5.34 -2.72 1.23 -5.77 -1.37 2.88 -0.85 -0.94 -0.56 -0.20 -0.51 -0.31 -0.47 1.86 3.53 -0.88 -1.37 0.49 -0.46 0.27 -1.17 0.02 -0.32 -0.43 -0.16 -0.15 -0.65 -0.13 -0.06 -0.69 0.02 0.05 -0.36 0.02 0.02 0.02 0.59 0.02
Change in cash -4.43 0.08 0.23 2.19 -2.86 -2.08 5.01 2.22 -1.94 -1.35 0.34 0.01 0.75 -0.49 0.64 0.03 0.49 -1.02 0.99 -0.51 0.81 -1.91 -6.93 6.10 -3.33 -1.52 2.12 -1.71 -5.69 -1.01 3.37 1.26 5.66 0.06 -3.92 2.80 -1.57 2.06 -1.58 3.32 0.17 -6.54 -1.11 6.55 -3.22 0.61 3.82 -2.52 2.33 4.29 0.10 -0.19 0.34 0.06 0.25 -0.07 0.17 -8.43 8.97 0.00 -0.93 0.93 -0.12 -0.46 0.55 -0.34 0.23 0.01 -0.60 0.17 0.24 0.06 0.40 -0.21 0.40 -0.10 -0.02 -0.08 0.26 -0.32 0.63 -0.44
Change in exchange rate -0.01 0.02 -0.04 -0.07 0.03 0.00 0.05 0.03 0.07 -0.10 0.05 0.03 0.06 -0.01 -0.01 0.02 -0.07 -0.03 -0.02 0.00 0.00 0.00 0.01 0.00 -0.01 0.01 0.01 -0.01 0.00 0.03 0.06 -0.03 -0.08 0.03 -0.08 0.08 0.05
about 2 months ago

GILEAD SCIENCES, INC. (GILD) - Shares Outstanding Diluted

1Y 2Y 5Y Max
about 2 months ago

GILEAD SCIENCES, INC. (GILD) - Change In Exchange Rate

1Y 2Y 5Y Max
about 2 months ago

GILEAD SCIENCES, INC. (GILD) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
about 2 months ago

GILEAD SCIENCES, INC. (GILD) - Net Income

1Y 2Y 5Y Max
about 2 months ago

GILEAD SCIENCES, INC. (GILD) - Stock Based Compensation

1Y 2Y 5Y Max
about 2 months ago

GILEAD SCIENCES, INC. (GILD) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
about 2 months ago

GILEAD SCIENCES, INC. (GILD) - Dividend Payout

1Y 2Y 5Y Max
about 2 months ago

GILEAD SCIENCES, INC. (GILD) - Cashflow From Financing

1Y 2Y 5Y Max
about 2 months ago

GILEAD SCIENCES, INC. (GILD) - Cashflow From Investment

1Y 2Y 5Y Max
about 2 months ago

GILEAD SCIENCES, INC. (GILD) - Change In Inventory

1Y 2Y 5Y Max
about 2 months ago